I nflammation contributes to the pathogenesis of pulmonary arterial hypertension (PAH), for which specific therapeutic targets remain elusive. 1,2 PAH is characterized by pulmonary artery vascular remodeling, which involves endothelial cell abnormalities, vascular smooth muscle cell (VSMC) proliferation, and perivascular inflammation. [3] [4] [5] Pulmonary vascular remodeling and progressive obliteration of the vessel lumen lead to right ventricular failure and premature death. 6 The key mechanisms of PAH include hypoxia, 7,8 increased local production of proinflammatory cytokines, and loss-of function mutations in bone morphogenetic protein receptor 2, 9 which affects platelet-derived growth factor (PDGF)-BB signaling. 10 There is a mechanistic link between inflammation and bone morphogenetic protein receptor 2 mutations in PAH. 11 This suggests a potential therapeutic target in the regulation of inflammation in pulmonary vasculature.
and elastic vessels and muscularization of more distal small vessels. 7 We have demonstrated that pulmonary vascular inflammation plays a crucial role in the development of hypoxia-induced pulmonary hypertension (PH), 13, 14 for which Rho-kinase plays a crucial role. [15] [16] [17] In addition, Rho-kinase promotes secretion of cyclophilin A (CyPA, encoded by Ppia) from VSMCs and extracellular CyPA stimulates VSMC proliferation in vivo 18 and in vitro. 19, 20 CyPA is secreted from VSMC through Rho-kinase activation and vesicle formation. 21 Extracellular CyPA induces endothelial cell adhesion molecule expression, 22 induces apoptosis, 23 and is a chemoattractant for inflammatory cells. 18, 24 Basigin (Bsg, also known as CD147 or EMMPRIN, encoded by Bsg) is an extracellular CyPA receptor. 25 Importantly, Bsg is an essential receptor for malaria, which disrupts nitric oxide metabolism and causes harmful endothelial activation, including the Rho/Rho-kinase activation. 26 Therefore, we hypothesized that the extracellular CyPA and Bsg signaling may contribute to hypoxia-induced PH.
Here, we report that CyPA +/and Bsg +/mice exhibit resistance to hypoxia-induced pulmonary vascular remodeling. Consistent with these results, plasma CyPA was significantly increased in patients with PAH and well correlated with the disease severity and long-term survival. Our data suggest that extracellular CyPA and its signaling through Bsg are novel therapeutic targets for PAH.
Methods

Animal Experiments
All animal experiments were conducted in accordance with the protocols approved by the Tohoku University Animal Care and Use Committee. Hypoxia-induced PH models were used to assess the effect of CyPA and Bsg deficiency on PH development in mice. Bsg is an important cell-surface molecule involved in early embryogenesis and reproduction. 27, 28 Because complete Bsg disruption (Bsg -/-) in mice results in perinatal lethality, poor pregnancy or abnormal development, we used Bsg +/mice in the present study. This is also the same in complete CyPA-deficient mice as to the poor pregnancy. 29 Twelve to 16- week-old male littermate control mice and Bsg +/and CyPA +/mice on a normal chow diet were exposed to hypoxia or normoxia for 4 weeks as previously described. 13, 14 Briefly, hypoxic mice were housed in an acrylic chamber with a nonrecirculating gas mixture of 10% O 2 and 90% N 2 by adsorption-type oxygen concentrator to use exhaust air (Teijin, Japan), whereas normoxic mice were housed in room air (21% O 2 ) under a 12-hour light-dark cycle. 13, 14 After 4 weeks of exposure to hypoxia (10% O 2 ) or normoxia, mice were anesthetized with isoflurane (1.0%). To determine the effect of CyPA and Bsg deficiency on hypoxia-induced PH development, we measured right ventricle systolic pressure (RVSP), right ventricular hypertrophy, and pulmonary vascular remodeling. 13, 14 For right heart catheterization, a 1.2-F pressure catheter (SciSense, Inc., Ontario, Canada) was inserted in the right jugular vein and advanced into the right ventricle (RV) to measure RVSP. 15 All data were analyzed using the PowerLab data acquisition system (AD Instruments) and averaged for 10 sequential beats.
Statistical Analyses in Animal Experiments
Results are expressed as mean±SEM for all studies except as mentioned in the figure legends. Comparisons of mean values between 2 groups were performed by Welch t test. Comparisons of mean responses associated with the 2 main effects of the different genotypes and the severity of pulmonary vascular remodeling were performed by 2-way ANOVA, followed by Tukey honestly significant difference multiple comparisons. All reported P values are 2-tailed, with a P value of <0.05 indicating statistical significance. Analyses were performed in SPSS, version 19.0 (Chicago, IL, USA) and R version 3.0.1. 30 An expanded Methods section is available in the Online Data Supplement.
Results
Increased CyPA Expression and Secretion in Patients With PAH
To confirm the role of CyPA in pulmonary arteries, we used lung tissues from patients with PAH undergoing lung transplantation. CyPA was strongly expressed in the remodeled pulmonary microvasculature in patients with PAH, especially in the medial layer ( Figure 1A ). Organ culture experiments revealed increased CyPA secretion (conditioned medium) from the lungs of patients with PAH as comparison with non-PAH controls ( Figure 1B ). Western blotting showed that hypoxia significantly increased CyPA secretion from VSMCs harvested from patients with PAH ( Figure 1C ). As we have shown in VSMCs harvested from mouse aorta, 29 a key role for Rho-kinase activity for CyPA secretion was shown by the marked decrease in CyPA secretion with hydroxyfasudil in pulmonary VSMCs from patients with PAH ( Figure 1C ). In addition, CyPA expression was time dependently increased in the pulmonary microvascular walls in hypoxia-induced PH in wild-type mice ( Figure 1D ; Online Figure IA) . Similarly, intense Bsg expression was noted in pulmonary arteries after hypoxic exposure, suggesting the crucial role of CyPA and Bsg in the pathogenesis of PH. Immunostaining with serial sections showed strong expression of CyPA and Bsg in the remodeled pulmonary arteries of patients with PAH, especially in the medial layer and adventitial inflammatory cells (Online Figure  IB) . Thus, we used CyPA +/and Bsg +/mice to examine the role of these molecules in the development of hypoxia-induced PH.
CyPA Deficiency Ameliorates Hypoxia-Induced PH In Vivo
CyPA promotes endothelial cell dysfunction, VSMC proliferation, and inflammatory cell migration. 31 Interestingly, we found hypoxia-induced increase of CyPA expression and inflammatory cells in lungs of wild-type mice (Online Figure I) . Thus, we first performed cytokine array to evaluate the levels of cytokines/chemokines and growth factors in CyPA +/and littermate controls (CyPA +/+ mice). We found significantly high levels of cytokines in the lung homogenates of CyPA +/+ mice compared with those of CyPA +/mice, irrespective of normoxia or hypoxia for 4 weeks (Online Figure II) . After 4 weeks of hypoxia, CyPA +/+ lungs exhibited increased inflammatory cytokines compared with CyPA +/lungs, especially in chemokine (C-X-C motif) ligand 2, macrophage colony-stimulating factor, interleukin (IL)-2 and IL-18, all of which contribute to pulmonary vascular remodeling ( Figure 1E ). The pulmonary arteries of normoxic CyPA +/and wild-type (CyPA +/+ ) mice did not differ in morphology ( Figure 1F ). In contrast, mice exposed to hypoxia for 4 weeks exhibited a difference in the medial thickness of pulmonary arteries ( Figure 1F ). In addition, CyPA +/+ mice exhibited increased RVSP, which was significantly attenuated in CyPA +/mice ( Figure 1G ). The increased ratio of RV to left ventricle plus septum weight [RV/(LV+sep)] was also attenuated in CyPA +/mice ( Figure 1H ), suggesting that CyPA is crucial in hypoxia-induced PH. These results suggest that CyPA is crucial for inflammation, VSMC proliferation, and development of hypoxia-induced PH in mice.
Bsg Deficiency Ameliorates Hypoxia-Induced PH In Vivo
To further evaluate the role of extracellular CyPA through Bsg signaling, we next performed analysis using Bsg +/mice and littermate controls (Bsg +/+ mice). Bsg expression was time dependently increased in the pulmonary microvascular walls in hypoxia-induced PH in wild-type mice (Figure 2A ; Online Figure I ). The morphology of pulmonary arteries in normoxic Bsg +/mice did not differ from those in Bsg +/+ mice ( Figure 2B ). In contrast, mice exposed to hypoxia for 4 weeks exhibited a significant difference in the medial thickness of pulmonary arteries ( Figure 2B ). The degree of muscularization was assessed in distal pulmonary arteries with a diameter of 20 to 70 μm.
As compared with Bsg +/+ mice, Bsg +/mice exhibited fewer muscularized distal pulmonary arteries after hypoxic exposure ( Figure 2C ). Muscularized distal pulmonary arteries exhibited immunoreactivity for α-smooth muscle actin ( Figure 2B ). Consistent with these morphological changes, Bsg +/+ mice exhibited increased RVSP, which was attenuated in Bsg +/mice ( Figure 2D ). The increased ratio of RV to left ventricle plus septum weight [RV/(LV+sep)] was also attenuated in Bsg +/mice ( Figure 2E ), suggesting a crucial role of Bsg in hypoxia-induced PH. Importantly, serum levels of growth factors and cytokines/ chemokines that promote PH (especially PDGF-BB) 32 were increased in hypoxic Bsg +/+ mice, which was significantly less in Bsg +/mice ( Figure 2F ). These results suggest that Bsg plays a crucial role in hypoxia-induced production and secretion of PDGF-BB and development of pulmonary vascular remodeling. We then examined hypoxia-induced changes in the number of perivascular inflammatory cells. Gross and histological examination of the lung revealed clear differences in CD45 + inflammatory cell migration between Bsg +/+ and Bsg +/mice (Online Figure III) . The increases in perivascular inflammatory cells in Bsg +/+ mice occurred as early as day 1, whereas it remained at low level in Bsg +/mice after 4 weeks of hypoxia ( Figure 3A and 3B). Consistent with the pathological changes in lung tissues, the levels of cytokines/chemokines, such as macrophage colony-stimulating factor, IL-15, and IL-18, were increased in hypoxic Bsg +/+ lung, which was again less dramatic in Bsg +/lung ( Figure 3C ). Importantly, growth factors such as PDGF-BB and eotaxin, both of which promote PH, 33 were also induced in Bsg +/+ mice, which were less strongly induced in Bsg +/mice ( Figure 3D ; Online Figure IV ).
To confirm whether the expression of CyPA is regulated by Bsg, we next performed immunostaining for CyPA in Bsg +/+ and Bsg +/mice. Perivascular expression of CyPA was comparable between normoxic Bsg +/+ and Bsg +/lung (Online Figure  VA) . In contrast, CyPA expression was greater in the muscularized vessels and perivascular inflammatory cells in Bsg +/+ and Bsg +/mice after hypoxic exposure (Online Figure VA) . Interestingly, the increase in CyPA expression in the pulmonary arteries was less dramatic in Bsg +/mice. We further performed Western blotting to compare the expression levels of CyPA between Bsg +/+ and Bsg +/lung (Online Figure VB) . Bsg expression was increased in the lung in Bsg +/+ and Bsg +/mice after hypoxic exposure (Online Figure VB) . However, there was no significant difference in CyPA expression between Bsg +/+ and Bsg +/mice (Online Figure VB) . Then, we performed Western blotting to compare the expression and secretion of CyPA from Bsg +/+ and Bsg +/-VSMCs (Online Figure VC) . Interestingly, the secretion of CyPA was less in Bsg +/-VSMCs compared with Bsg +/+ VSMCs. Moreover, extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation was less in Bsg +/-VSMCs compared with Bsg +/+ VSMCs (Online Figure VD) .
Vascular Bsg Is Essential for Hypoxia-induced PH
Extracellular CyPA stimulates migration of inflammatory cells. 24 The chemotactic activities of extracellular CyPA depend on Bsg, which serves as the primary binding site for CyPA on target cells. 25 Inflammation is augmented by cytokines/chemokines and growth factors secreted from perivascular inflammatory cells. To determine whether extracellular CyPA induces secretion of growth factors in a Bsg-dependent manner, we stimulated Bsg +/bone marrow cells with human recombinant CyPA ex vivo. Inflammatory cytokine secretion was induced by human recombinant CyPA in Bsg +/+ bone marrow cells (Online Figure  VIA) ; however, the bone marrow from Bsg +/mice exhibited a poorer response. This suggests that Bsg plays a crucial role for extracellular CyPA-induced secretion of cytokines/chemokines. Bsg regulates the survival, proliferation, and adhesion of T-lymphoma cells. 34 Bone marrow-derived cells are involved in the pathogenesis of PH. 13, 14, 35 Therefore, we hypothesized that Bsg deficiency in bone marrow-derived cells may impair hypoxia-induced PH in Bsg +/mice. To test this hypothesis, Bsg +/+ bone marrow cells (GFP + [green fluorescent protein]) were transplanted into irradiated Bsg +/+ and Bsg +/mice. After reconstitution of the bone marrow, chimeric mice were exposed to normoxia or hypoxia for 4 weeks. GFP expression did not differ in the whole lungs from chimeric mice exposed to normoxia ( Figure 4A) ; however, the number of bone marrow-derived cells (GFP + cells) was significantly less in the pulmonary arteries in Bsg +/recipient mice as compared with Bsg +/+ recipient mice ( Figure 4A ). As shown in the 3-dimensional image of a pulmonary artery ( Figure 4A ), GFP + cells adhered to the adventitia after hypoxic exposure. The reduced number of GFP + cells in the distal pulmonary arteries of the Bsg +/recipient mice suggests that Bsg expressed in the distal pulmonary arteries mediates inflammatory cell recruitment. Consistently, the levels of cytokines/chemokines and growth factors in the lung were significantly lower in Bsg +/versus Bsg +/+ recipient mice, regardless of the source September 26, 2014 of bone marrow (Online Figure VIB and VIC) . These results support the concept that the reduced inflammatory responses in Bsg +/mice are because of Bsg deficiency in the recipient lung. Finally, the development of PH assessed by RVSP and right ventricular hypertrophy was consistently less severe in Bsg +/than in Bsg +/+ recipient mice, regardless of the source of bone marrow ( Figure 4B ). These data suggest that pulmonary vascular Bsg, but not bone marrow-derived Bsg, is critical for the VSMC proliferation and the development of pulmonary vascular remodeling ( Figure 4C ). mice and littermate controls (Bsg +/+ ) exposed to normoxia or hypoxia (10% O 2 ) for 4 weeks. Although the morphology of pulmonary arteries was comparable between Bsg +/and Bsg +/+ mice under normoxia, a significant difference in the medial thickness of pulmonary arteries was noted when exposed to hypoxia for 4 weeks between the 2 genotypes. The predominant cellular component in the remodeled distal pulmonary arteries was vascular smooth muscle cells as evidenced by immunostaining for α-smooth muscle actin (αSMA) in serial sections. Scale bars, 50 μm. C, Muscularization was assessed in distal pulmonary arteries with a diameter of 20 to 70 μm. Under normoxia, there was no difference in muscularization between normoxic Bsg +/+ (n=7) and Bsg +/mice (n=6). However, after chronic hypoxia, Bsg +/mice (n=15) exhibited less muscularized vessels as compared with Bsg +/+ mice (n=9). *P<0.05. D, The development of hypoxia-induced PH assessed by right ventricular systolic pressure (RVSP) was significantly attenuated in Bsg +/mice as compared with Bsg +/+ mice after 4 weeks of hypoxic exposure. In contrast, there was no difference in RVSP between the 2 genotypes. Results are expressed as mean±SD. *P<0.05. E, After hypoxic exposure for 4 weeks, the increased ratio of right ventricle to left ventricle plus septum weight [RV/(LV+sep)] was significantly attenuated in Bsg +/than in Bsg +/+ mice. Results are expressed as mean±SD. *P<0.05. F, Serum levels of inflammatory cytokines and growth factors after hypoxic exposure for 7 days were significantly lower in Bsg +/mice (n=9) than in Bsg +/+ (n=6). Results are expressed as mean±SEM. *P<0.05. CCL indicates chemokine (C-C motif) ligand; CXCL, chemokine (C-X-C motif) ligand; EM, Elastica-Masson; FGF2, fibroblast growth factor 2; G-CSF, granulocyte-colony stimulating factor; GM-CSF, granulocyte macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; LIF, leukemia inhibitory factor; M, fully muscularized vessels; M-CSF, macrophage colony-stimulating factor; MCP, monocyte chemoattractant protein; N, nonmuscularized vessels; P, partially muscularized vessels; PDGF-BB, platelet-derived growth factor-BB; RANTES, regulated on activation, normal T cell expressed and secreted; TNF, tumor necrosis factor; and VEGF, vascular endothelial growth factor.
Bsg Regulates Secretion of Cytokines and Growth Factors In Vivo and In Vitro
To confirm the roles of growth factors in circulation and local lung, we harvested pulmonary VSMCs from wild-type mice and stimulated them with serum or lung homogenates from Bsg +/+ or Bsg +/mice ( Figure 5A ). VSMC proliferation was significantly increased by treatment with serum and lung homogenates from hypoxic Bsg +/+ mice as compared with normoxic Bsg +/+ mice ( Figure 5A ). Moreover, VSMC proliferation was attenuated by the treatment with serum or lung homogenates from Bsg +/mice than those from Bsg +/+ mice.
This suggests that the reduced levels of growth factors may contribute to the amelioration of PH in Bsg +/mice.
The pathogenesis of PAH in humans is complex, depending on the interactions of genetic predisposition, metabolic problems, and inflammation/infection. 32 Because extracellular CyPA activates ERK1/2 through Bsg, 25 we anticipated decreased ERK1/2 activity in the absence of Bsg in VSMCs. To evaluate the role of Bsg in VSMC proliferation, we harvested pulmonary VSMCs from Bsg +/+ and Bsg +/mice. 36 As anticipated, ERK1/2 activity and proliferation were lower in Bsg +/-VSMCs than in Bsg +/+ VSMCs ( Figure 5B ). The expression of nuclear factor E2-related factor-2 and its downstream heme oxygenase-1, both of which inhibit VSMC proliferation, 37, 38 were induced in Bsg +/as compared with Bsg +/+ VSMCs ( Figure 5C ). Integrin α3 was inhibited in Bsg +/as compared with Bsg +/+ VSMCs under both normoxic and hypoxic conditions ( Figure 5C ). These data support the impaired inflammatory cell migration in the Bsg +/lung.
To characterize the mechanisms by which CyPA/Bsg signaling participates in hypoxia-induced VSMC proliferation, we examined the secretion of growth factors from VSMCs in vitro. Stimulation of Bsg +/+ VSMCs with human recombinant CyPA and hypoxia promoted secretion of several cytokines/ chemokines and growth factors, especially monocyte chemoattractant protein-1 (MCP-1), fibroblast growth factor 2 (FGF-2), chemokine (C-X-C motif) ligand 9 (monokine induced by gamma interferon [MIG]), and IL-15 ( Figure 5D ). Furthermore, Bsg deficiency blocked the secretion of these molecules, especially in MCP-1 and chemokine (C-X-C motif) ligand 9 (MIG; Figure 5D ). These data suggest that extracellular CyPA mediates an autocrine/paracrine function in VSMC proliferation partly through Bsg stimulation. However, we do not have a plausible explanation why the secretion of MCP-1 and chemokine (C-X-C motif) ligand 9 was specifically promoted by extracellular CyPA/ Bsg signaling. Further analyses will provide us clues to understand the mechanism. Finally, Bsg expression in Bsg +/+ VSMCs was induced by extracellular CyPA and was further augmented by hypoxia ( Figure 6A ). Thus, extracellular CyPA and VSMC Bsg are crucial for hypoxia-induced inflammation, thereby promoting VSMC proliferation by inducing growth factor secretion and inflammatory cell recruitment ( Figure 6B ).
Plasma CyPA Is Associated With the Prognosis of Patients With PAH
Finally, we aimed to confirm the role of extracellular CyPA in the pathogenesis of PAH in humans. We examined human recombinant CyPA-induced secretion of growth factors from VSMCs harvested from the pulmonary arteries of patients with idiopathic PAH. Extracellular CyPA induced secretion of growth factors and chemokines (eg, PDGF-BB, SDF-1 [stromal cell-derived factor], and FGF-2) and inflammatory cytokines (eg, IL-1β, IL-2, and tumor necrosis factor-α) and this effect was enhanced by hypoxia ( Figure 7A ; Online Figure VII) . These results support the notion that extracellular CyPA promotes the secretion of growth factors from VSMCs in patients with PAH. Thus, we anticipated increased plasma levels of CyPA in patients with PAH. The clinical characteristics and laboratory data of patients with PAH are shown in Online Table I and Online Figure VIII . As anticipated, plasma CyPA levels were elevated in patients with PAH as compared with those without Figure 7B ). Finally, the event-free curve revealed that high plasma CyPA levels (>22 ng/mL) were associated with poor outcome (death or lung transplantation; Figure 7C ), suggesting that plasma CyPA is a novel biomarker of disease severity, therapeutic efficacy, and prognosis in patients with PAH.
Discussion
The major finding of this study is that CyPA/Bsg signaling is a novel promoter of PH. We demonstrated that extracellular CyPA and vascular Bsg are crucial for hypoxia-induced PH by inducing growth factor secretion, inflammatory cell recruitment, and VSMC proliferation. The central player in CyPA/Bsg-mediated PH development seems to be cells resident in the vessel wall, especially VSMCs. The development of PH in Bsg +/+ recipient mice did not differ, even after transplantation of Bsg +/+ or Bsg +/bone marrow. In addition, PH severity was exacerbated in Bsg +/+ versus Bsg +/recipient mice, regardless of the bone marrow source (Bsg +/+ or Bsg +/-). Based on these findings, we propose that hypoxia induces growth-promoting genes in VSMCs through a CyPA/Bsg-dependent pathway, a novel mechanism for hypoxia-induced PH. These results suggest that extracellular CyPA and vascular Bsg are crucial for PH development and are potential therapeutic target for cardiovascular diseases.
Vascular Bsg Regulates Pulmonary Vascular Remodeling
We have shown that CyPA is strongly expressed at coronary segments with unstable atherosclerotic plaques and is increased in the plasma of patients with coronary artery disease 39 ; however, the role of extracellular CyPA and its signaling pathway in vivo remained to be examined. In this study, we thus aimed to characterize the role of extracellular CyPA in hypoxia-induced PH and its Bsg-mediated mechanisms.
The present results provide mechanistic insights into CyPA-mediated cardiovascular diseases. Specifically, we propose that vascular Bsg regulates CyPA-mediated pulmonary vascular remodeling and inflammation that leads to PH for the following reasons. First, we demonstrated that growth factor secretion is attenuated in CyPA +/and Bsg +/mice, resulting in decreased inflammation and vascular remodeling. Second, hypoxia promoted secretion of CyPA from VSMCs, cytokines/chemokines, and growth factors, resulting in Bsgmediated activation of the ERK1/2 signaling pathway. Third, Bsg +/-VSMCs exhibited increased expression of nuclear factor E2-related factor-2 and heme oxygenase-1, which inhibit hypoxia-induced PH. 40, 41 Consistently, in Bsg +/-VSMCs, proliferation of VSMCs was inhibited and integrin expression and secretion of growth factors were also inhibited in response to extracellular CyPA and hypoxia. Thus, extracellular CyPA and vascular Bsg cooperatively stimulate recruitment of inflammatory cells to the vessel wall, exacerbating perivascular inflammation and VSMC proliferation. Thus, the cooperative interaction between extracellular CyPA and pulmonary vascular Bsg is critical for the process of hypoxia-induced PH. C, The Kaplan-Meier curve shows that patients with high plasma CyPA (≥22.0 ng/mL) had more cardiovascular events than those with low plasma CyPA (<22.0 ng/mL). *P<0.05. CCL indicates chemokine (C-C motif) ligand; FGF, fibroblast growth factor; IL, interleukin; MIP, macrophage inflammatory proteins; PDFG-BB, platelet-derived growth factor-BB; RANTES, regulated on activation, normal T cell expressed and secreted; SDF, stromal cell-derived factor; and TNF, tumor necrosis factor. September 26, 2014
Vascular Bsg Promotes Growth Factor Secretion and Inflammation
We further propose a key role for CyPA/Bsg signaling in pulmonary vascular remodeling. Specifically, we propose that hypoxia-induced secretion of growth factors and cytokines/ chemokines requires CyPA/Bsg signaling in the pulmonary vasculature. A recent in vivo study showed that Bsg in circulating inflammatory cells functions as a CyPA receptor. 42, 43 Consistently, in the present study, Bsg expression was intense in the perivascular inflammatory cells of animal models of PH and patients with PAH. The migration of inflammatory cells to the pulmonary arteries was reduced in Bsg +/mice, as was the secretion of inflammatory cytokines/chemokines in the lung. However, against our initial hypothesis, hypoxia-induced migration of GFP + cells was significantly reduced in Bsg +/versus Bsg +/+ recipient mice even after we transplanted GFP + bone marrow cells from the same donor mouse. PH development was dependent on Bsg expression in the recipient mice but not in the bone marrow cells. These results suggest that the main function of Bsg in CyPA-mediated vascular remodeling and PH is not in the inflammatory cells but in the pulmonary vascular Bsg. Bsg induces Rac-1-dependent expression of inflammatory cytokines 44 and promotes VSMC proliferation. 45 These reports support our notion that the secretion of inflammatory cytokines was augmented by cooperative interaction between extracellular CyPA and Bsg in the pulmonary vasculature. Thus, we conclude that vascular CyPA/Bsg signaling is central to the secretion of growth factors, recruitment of inflammatory cells, and pulmonary vascular remodeling.
Clinical Implications
A key aspect of this study that deserves comment is the strong expression of CyPA and Bsg in the pulmonary arteries of animal models of PH and patients with PAH. We have previously reported that statins and Rho-kinase inhibitors reduce CyPA secretion from VSMCs. 29, 46 Rho-kinase is an important therapeutic target in cardiovascular diseases 47 and Rho-kinase inhibition ameliorates PH in animals and humans. 39, [48] [49] [50] Based on the present study, inhibition of CyPA secretion by Rho-kinase inhibitors may contribute to the therapeutic efficacy of these drugs in PAH. 48, 49 Children with severe malaria have been reported to develop PH. 51 The mechanisms of these complications remain elusive. When we consider the role of Bsg as an essential receptor for erythrocyte invasion by Plasmodium falciparum, 52 Bsg may contribute to the pathogenesis of PH in patients with severe malaria. Indeed, a recent article demonstrated Bsg expression in VSMCs, 53 a process that may be activated by binding of extracellular CyPA. 25 In addition, Bsg stimulates MMP production. 54 We demonstrated that Bsg is strongly expressed in the pulmonary arteries of patients with PAH. Thus, it is logical to consider that pharmacological agents that prevent the interaction of extracellular CyPA and vascular Bsg could be useful for the treatment of PAH.
Effective management of PAH requires comprehensive prognostic evaluation to determine optimal management strategies. 55 Although several clinical and hemodynamic parameters linked to PAH prognosis have been identified, some are associated with significant limitations such as invasive techniques and subjective measures. Thus, there is a need for a noninvasive biomarker for diagnosis and assessment of disease prognosis that can predict therapeutic response in patients with PAH. The identification of CyPA as a novel biomarker and mediator of PH associated with inflammation provides insight into the mechanisms of several therapies.
Potential Bsg-Independent Functions of CyPA and Conclusions
Our previous work implicated an increase in reactive oxygen species signaling in VSMCs by extracellular CyPA. 31 As to the role of reactive oxygen species in hypoxia-induced PH model in mice, PAH in humans and in VSMCs in hypoxia is an issue with significant conflicts and controversies. 56 More studies are needed to address this issue. [57] [58] [59] [60] Thus, in the present study, we focused on the Bsg-mediated secretion of CyPA, cytokines/chemokines, and growth factors. In this process, we think that the extracellular CyPA and VSMC Bsg play a crucial role for connecting cell-cell interaction, inflammation, and VSMC proliferation.
Next, we need to discuss as to the Bsg-independent functions of CyPA. Beside the role of extracellular CyPA, there is a potential role of intracellular CyPA on NFAT activation. 61 CyPA has been found as a binding partner of cyclosporine A, which is an immunosuppressive drug in clinical use. 31 It has been established that the CyPA-cyclosporine A complex binds to and inactivates calcineurin, which activates nuclear factor of activated T cells transcription factors. 61 Because this step is important for cytokine/chemokines production and secretion, inhibition of calcineurin by cyclosporine A exerts anti-inflammatory effects. Here, there is strong evidence of an important role of NFAT in PAH in both the PA VSMC and the infiltrating inflammatory cells. 57, 62, 63 One of the mechanisms for the decreased PH in our models could be the suppression of NFAT signaling. 64 Thus, there is a potential Bsg-independent role of intracellular CyPA on NFAT activation in the development of PAH, and the mechanisms for the decreased PH in our models could be the suppression of NFAT signaling.
Finally, it has been reported already that extracellular CyPA augments endothelial expression of E-selectin. 22 Bsg is also suggested to augment inflammation partly through E-selectin expression on neutrophil. 65 However, in our hypoxia-induced PH model in mice, there was no significant change in E-selectin expression in lung tissues. This suggests the possible importance of Bsg in the specific conditions of hypoxia, which augments inflammation through extracellular CyPA.
In conclusion, the present study suggests that extracellular CyPA and pulmonary vascular Bsg provide a novel therapeutic target for patients with PAH.
